Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Engler

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Clinical Microbiology|March 28, 2014
Evaluation of the Remel RapID NF plus rapid biochemical method for identification of Burkholderia pseudomalleiSamuel Maloney, Cathy Engler, Robert Norton
International Journal of Antimicrobial Agents|April 13, 2011
Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacinPatrick Harris, Cathy Engler, Robert Norton
Journal of Global Antimicrobial Resistance|July 22, 2017
Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution methodSamuel Maloney, Cathy Engler, Robert Norton
Neonatal Network : NN|September 2, 2009
Trichophyton tonsurans-Ringworm in an NICUAnn Vivian Sproul, John Whitehall, Cathy Engler
International Journal of Antimicrobial Agents|October 19, 2006
Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine modelMarshall Feterl, Brenda Govan, Cathy Engler, et al.
Journal of Clinical Microbiology|March 13, 2009
Comparison of routine bench and molecular diagnostic methods in identification of Burkholderia pseudomalleiKelly Hodgson, Cathy Engler, Brenda Govan, et al.
The American Journal of Tropical Medicine and Hygiene|June 27, 2018
Activity of Ceftolozane-Tazobactam against <i>Burkholderia pseudomallei</i>Andrew Slack, Fiona Parsonson, Katie Cronin, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Clinical Microbiology|March 28, 2014
Evaluation of the Remel RapID NF plus rapid biochemical method for identification of Burkholderia pseudomalleiSamuel Maloney, Cathy Engler, Robert Norton
International Journal of Antimicrobial Agents|April 13, 2011
Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacinPatrick Harris, Cathy Engler, Robert Norton
Journal of Global Antimicrobial Resistance|July 22, 2017
Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution methodSamuel Maloney, Cathy Engler, Robert Norton
Neonatal Network : NN|September 2, 2009
Trichophyton tonsurans-Ringworm in an NICUAnn Vivian Sproul, John Whitehall, Cathy Engler
International Journal of Antimicrobial Agents|October 19, 2006
Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine modelMarshall Feterl, Brenda Govan, Cathy Engler, et al.
Journal of Clinical Microbiology|March 13, 2009
Comparison of routine bench and molecular diagnostic methods in identification of Burkholderia pseudomalleiKelly Hodgson, Cathy Engler, Brenda Govan, et al.
The American Journal of Tropical Medicine and Hygiene|June 27, 2018
Activity of Ceftolozane-Tazobactam against <i>Burkholderia pseudomallei</i>Andrew Slack, Fiona Parsonson, Katie Cronin, et al.
Pageof 1